Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell-cycle inhibitor profiling by high-content analysis.

Fabio Gasparri1, Antonella Ciavolella, Arturo Galvani

  • 1Department of Biology, Nerviano Medical Sciences, Milano, Italy. fabio.gasparri@nervianoms.com

Advances in Experimental Medicine and Biology
|August 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Robust siRNA Screening Approach with Optimized Conditions for Large-Scale Transfection in Multiple Human Cancer Cell Lines.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Novel Thienoduocarmycin-Trastuzumab ADC Demonstrates Strong Antitumor Efficacy with Favorable Safety Profile in Preclinical Studies.

Molecular cancer therapeutics·2023
Same author

Stereoselective synthesis of 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2H)-one derivatives as PIM kinase inhibitors inspired from marine alkaloids.

Chirality·2022
Same author

Identification of unprecedented ATP-competitive choline kinase inhibitors.

Bioorganic & medicinal chemistry letters·2021
Same author

EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors.

Pharmaceutics·2021
Same author

The Coup-TFII orphan nuclear receptor is an activator of the γ-globin gene.

Haematologica·2020

This study introduces a High-Content Analysis (HCA) method to screen for novel cancer cell division inhibitors. The approach uses multiparametric cellular analysis to confirm the mechanism of action for potential oncology drugs.

Area of Science:

  • Oncology
  • Cell Biology
  • Drug Discovery

Background:

  • Targeting cell-cycle machinery is crucial for oncology drug discovery.
  • Multiparametric cellular analysis aids in confirming the mechanism of action (MOA) of compounds.
  • High-Content Analysis (HCA) uses automated microscopy for detailed cellular response assessment.

Purpose of the Study:

  • To present a multiparametric HCA approach for characterizing potential cell-cycle inhibitors.
  • To evaluate compound-induced cell-cycle perturbations in osteosarcoma U-2 OS cells.
  • To establish a cellular and molecular phenotype fingerprint for each compound.

Main Methods:

  • Utilized automated microscopy and multiparametric analysis of fluorescent indicators.
  • Monitored specific cellular markers: nuclear morphology, DNA content, and histone H3 phosphorylation.

Related Experiment Videos

  • Assessed DNA damage response and apoptosis induction across various compound concentrations.

    • Main Results:

    • Developed a HCA approach to characterize cell-cycle inhibitors in osteosarcoma cells.
    • Enabled monitoring of compound-induced cell-cycle perturbations and associated cellular responses.
    • Generated compound-specific fingerprints based on cellular marker profiles.

    Conclusions:

    • Multiparametric HCA is effective for characterizing potential cell-cycle inhibitors.
    • This method facilitates the confirmation of MOA for oncology drug candidates.
    • The fingerprinting approach aids in understanding compound-induced cellular phenotypes.